DIGITAL PHARMACY

AI in Pharmacy

DI
Dr. Inas Al Khatib
AI Transformation Leader
📅 November 14, 2025
🕑 7 min read
💬 0 comments

Why Pharmacists Resist Change: Understanding the Pushback Against AI in Healthcare, including residency-level resistance and generational differences

Artificial intelligence continues to reshape healthcare, transforming diagnostics, triage, documentation, fill accuracy, and decision support. Yet among major healthcare stakeholders, pharmacists often show some of the strongest skepticism and slowest adoption of AI-driven tools. While not universal across the profession, the pattern is consistent enough that it warrants discussion.

And the resistance is not equal across all pharmacists. It tends to spike in two specific groups: pharmacy residents (especially those transitioning from school to practice), and older, late-career pharmacists.

Interestingly, their reasons for resisting AI are very different, even though the behavior looks similar from the outside.

You may expect pharmacy residents, young, tech-native, highly credentialed, to be early champions of AI. But many residency programs report the opposite. Resistance at the residency level is often tied to professional identity formation and perceptions of competence.

Residents are in a phase where they are: proving themselves, trying to validate the years of study they just completed, and Shaping their clinical identity.

AI tools that automate dosing decisions, therapeutic substitutions, or clinical pathways can feel like they devalue the resident’s growing skillset.

Perception: “How can I show my clinical judgment if the AI step in before I do?”

Residency culture emphasizes: critical thinking, manual calculations, and independent verification

AI can be perceived as a shortcut the preceptor may penalize.

Residents often avoid AI because they fear labels like: lazy, overly dependent, and not clinically mature

Even when AI would help, the social risk feels greater than the operational benefit.

Pharmacy school may teach future-focused technology, but residency bases performance on evidence-based practice, established protocols, and manual decision-making.

This creates a perception that AI is not “real pharmacy work”.

AI resistance also varies dramatically by age group.

Typically: more comfortable with technology, more open to automation and less threatened by role evolution

However, they still resist when AI appears to reduce the need for their clinical expertise or jeopardize their credibility.

This group is often the most balanced pragmatic, burned by bad systems in the past, hopeful for tools that save time, and skeptical of hype

Their resistance is usually workflow-related: “If it slows me down, I am out”.

This group tends to have strong professional autonomy, established patterns and mental models, comparatively lower trust in new systems, high discomfort with black-box logic, and limited time or incentive to retrain.

Their resistance is driven by loss aversion, not fear of irrelevance: “I have practiced safely for decades without this. Why add risk now?”

They also carry memory of early electronic pharmacy systems that were glitchy, rigid, and disruptive, making them skeptical that AI will be any different.

Regardless of age or training, perception significantly intensifies resistance. The following beliefs, whether accurate or not, shape behavior:

  • “AI is developed by people who don’t understand pharmacy workflow”: A perception often based on experience with poorly implemented EHRs and dispensing systems.
  • “AI will make my job harder, not easier”: Past technology rollouts have conditioned pharmacists to expect added burden, not relief.
  • “My value is tied to accuracy and expertise, AI erodes that”: This hits hardest at residents and pharmacists whose identity is tightly connected to their clinical role.

Compared to physicians or nurses, pharmacists see AI directly overlap with:

  • Dosing and kinetics
  • Medication therapy recommendations
  • Inventory and dispensing automation

In other words, AI is not just assisting in their workflow, it threatens to redefine it. This creates a more intense sense of vulnerability and thus more pushback.

Resistance Is not Stubbornness, it is Identity, Risk, and Perception. Pharmacists are not inherently anti-technology. Their resistance to AI arises from a combination of professional identity concerns, liability fears, past negative experiences with digital tools, workflow pressures, role protection, generational perceptions about competence and expertise

Pharmacy residents resist because AI threatens their emerging identity. While older pharmacists resist because AI challenges long-standing practice norms. However, mid-career pharmacists resist when AI violates workflow reality. Understanding these drivers is not just useful, it is essential for designing AI tools that pharmacists will actually adopt in the MENA region and globally.

“AI‑Driven pharmacy practice: Unleashing the revolutionary potential in medication management, pharmacy workflow, and patient care” – Pharmacy Practice AI-Driven pharmacy practice: Unleashing the revolutionary potential in medication management, pharmacy workflow, and patient care | Pharmacy Practice

“Prescribing the Future: The Role of Artificial Intelligence in Pharmacy” – MDPI, Information – Prescribing the Future: The Role of Artificial Intelligence in Pharmacy

“The impact of various artificial intelligence applications in pharmacy practice: A narrative review” – Journal of Pharmacy & Therapeutics / JPTCP The impact of various artificial intelligence applications in pharmacy practice: A narrative review | Journal of Population Therapeutics and Clinical Pharmacology

“Regulating AI in health in the Middle East: case studies from Qatar, Saudi Arabia and the United Arab Emirates” – NCBI / NCBI Bookshelf Regulating AI in health in the Middle East: case studies from Qatar, Saudi Arabia and the United Arab Emirates – Research Handbook on Health, AI and the Law – NCBI Bookshelf

“A scoping review on the impact of versatile Digital Health innovations on pharmacy education” – Frontiers in Medicine https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2025.1577494/full

“Human‑machine cooperation: optimization of drug retrieval sequencing in automated drug dispensing systems” – arXiv [2312.11306] Human-machine cooperation: optimization of drug retrieval sequencing in automated drug dispensing systems

“Optimizing Drug Delivery in Smart Pharmacies: A Novel Framework, Adaptive Robotics Mechanism” – arXiv – [2410.00753] Optimizing Drug Delivery in Smart Pharmacies: A Novel Framework of Multi-Stage Grasping Network Combined with Adaptive Robotics Mechanism

“Adaptive User Journeys in Pharma E‑Commerce with Reinforcement Learning: Insights from SwipeRx” –  arXiv – [2408.08024] Adaptive User Journeys in Pharma E-Commerce with Reinforcement Learning: Insights from SwipeRx

“Artificial Intelligence in pharmaceutical supply chain management: A systemic review” – WJB PHS Journal – Artificial Intelligence in pharmaceutical supply chain management: A systemic review

Deloitte Middle East – “Transforming healthcare in the Middle East” Transforming healthcare in the Middle East | Deloitte Middle East

PharmBot AI – “Why Saudi Arabia Is Ready for AI in Pharmacy” Why Saudi Arabia Is Ready for AI in Pharmacy – Phambot AI

Aumet – “AI in Pharmacy Operations: Aumet’s Role in Innovation” AI in Pharmacy Operations: Aumet’s Role in Innovation – Aumet

Journal of Health, Population and Nutrition – “The digital transformation in pharmacy: embracing online platforms The digital transformation in pharmacy: embracing online platforms and the cosmeceutical paradigm shift | Journal of Health, Population and Nutrition | Full Text

Leave a Comment